Breast cancer is the most diagnosed cancer globally. While the breast cancer prevalence continues to rise, so too do patient survival rates, thus resulting in a large survivor population. Up to 75% of this population report experiencing cancer-related cognitive impairment during their cancer journey, thus reducing their quality of survivorship. This review systematically evaluates the effect of physical activity and exercise training on cerebrovascular function and cognition in breast cancer survivors. Cross-sectional, intervention or observational studies that examined the effect of acute or chronic exercise training or physical activity levels on cerebrovascular function and cognition in female breast cancer survivors were searched for systematically. The 11 included studies were tabulated and described narratively. The included studies primarily focused on aerobic exercise training, while only four studies investigated the effect of resistance exercise training or concurrent training on cerebrovascular function and/or cognition in breast cancer survivors. Collectively, these studies provide preliminary evidence supporting the positive effect of exercise training on cerebrovascular function and cognition in breast cancer survivors, irrespective of their age, stage of breast cancer and treatment regimen. However, more research is required to comprehensively evaluate the effect of exercise training on cerebrovascular function and cognition in breast cancer survivors and the mechanisms leading to these potential improvements.
Background/Objectives: Cerebrovascular function and cognition decline with age and may be further exacerbated by obesity. Capsaicin may improve cerebrovascular function and cognition, although evidence in humans is lacking. We investigated the effects of 12 weeks of capsaicin supplementation on cerebrovascular function and cognition in middle-aged and older adults who were overweight or obese. Methods: Forty participants were randomly allocated to receive 200 mg/day of Capsifen® or a placebo, with 34 completing the intervention (n = 17 in both). Before and after supplementation, transcranial Doppler ultrasonography was used to measure the cerebrovascular responsiveness (CVR) to physiological (hypercapnia, 5% carbon dioxide) and cognitive stimuli, while cognition was assessed using a comprehensive cognitive battery. The trial was prospectively registered (ACTRN12623000556640). Results: Total CVR to cognitive stimuli increased following Capsifen® supplementation (18 ± 3% to 21 ± 1%) and decreased in the placebo group (21 ± 4% to 19 ± 3%; p = 0.0002). Total cognition increased following Capsifen® supplementation (98 ± 18 to 107 ± 18) compared with the placebo (105 ± 13 to 106 ± 10; p = 0.0085). Capsifen® did not alter CVR to hypercapnia (30 ± 18% to 44 ± 27% vs. 39 ± 23% to 32 ± 16%; p = 0.5981). Working memory, executive function and exercise performance also improved, while waist circumference and waist-to-hip ratio decreased. Conclusions: Twelve weeks of Capsifen® supplementation improved total cognition and CVR to cognitive stimuli but not CVR to hypercapnia. These findings provide preliminary evidence that chronic capsaicin supplementation may improve cognition and neurovascular coupling in humans.